Our results showed that the adoptive transfer of SLAMF6+ PD-1+ CD8+ T cells, but not SLAMF6- PD-1+ CD8+ T cells, could promote DPVB-mediated tumor regression by enhancing the cytotoxic capacity of CD8+ T cells (Fig. 4e–h). The gene discussed is CD8A; the disease is neoplasm.